
Studies suggest a clinical benefit of optimal magnesium status in the prevention of conditions including metabolic syndrome, diabetes, heart disease, stroke, atherosclerosis, and hypertension.

Studies suggest a clinical benefit of optimal magnesium status in the prevention of conditions including metabolic syndrome, diabetes, heart disease, stroke, atherosclerosis, and hypertension.

An independent study on Ingredion's food ingredient found that Hi-Maize promotes the expression of some key enzymes.

In looking at 235 different types of rice, researchers found the GI of rice to be anywhere from 48 to 92.

In a published journal study in June, Zychrome was shown to be twice as effective as chromium picolinate in improving insulin function,

Specializing in herbal extracts, with manufacturing done per GMP standards, the company offers comprehensive solutions for the natural product industry’s raw material needs.

For decades, European doctors have prescribed diabetic patients benfotiamine to treat neuropathies and to help prevent complications such as blindness, kidney failure, heart attack, and limb amputation.

Iranian researchers assigned type 2 diabetics to broccoli sprout powder or placebo.

The company will host two education seminars on nutrigenomics this May.

The product contains a proportion of chlorogenic acid that inhibits the enzyme glucose-6-phosphatase-slowing the release and creation of excess glucose in the body.

Manufactured by Enzymotec (Migdal HaEmek, Israel), the ingredient is clinically proven to provide cardiovascular benefits.

Zychrome was deemed 1.4-fold and 2.0-fold more effective than chromium picolinate in controlling insulin levels and insulin functions respectively, according to the company.

In a move sure to shake up the global sweetening industry, steviol glycosides have been approved for use in foods sold in the European Union.

A new functional spice can be sprinkled on starchy food, both adding flavor and lowering food’s glycemic index.

InnoVactiv Inc. (Rimouski, QC, Canada) has announced the publication of two new studies on InSea2, the company’s brown seaweed-based polyphenol ingredient for diabetes management.

The original UltraMeal PLUS 360°is touted for managing metabolic syndrome, including reducing risk factors for cardiovascular disease.

More than 70% of 374 diabetes educators surveyed at the American Association of Diabetes Educators annual meeting said they would recommend Zychrome.

Today, the term clinical nutrition seems to stretch from intensive care to products that would not look out of place in a supermarket. What unites them is science, hard-health economics, and attractive margins.

Iranian researchers assigned 63 type 2 diabetes patients to placebo or broccoli sprout powder (10 g or 5 g) daily for four weeks.

The studies were published in the American Journal of Clinical Nutrition and the European Journal of Clinical Nutrition.

Of note, numerous health claims submitted for soy isoflavones were rejected.

Atrium Innovations Inc. (Quebec City, QC, Canada) is investing in a $5 million research program to study nutritional therapies for metabolic syndrome.

On July 4, an EU committee recommended the natural sweetener be pushed forward in the regulatory process.

The study involved 10 overweight but healthy adults who consumed 100 g of Sambazon-brand acai frozen fruit pulp twice daily before meals.

The company says this was the first study to examine the lower dose of 15 g/day.

The ingredient significantly lowered both circulating glucose and insulin levels after subjects consumed 70 g of sucrose.